EP 1957048 A2 20080820 - SOLID ORALLY ADMINISTERABLE PHARMACEUTICAL DOSAGE FORMS WITH RAPID ACTIVE PRINCIPLE RELEASE
Title (en)
SOLID ORALLY ADMINISTERABLE PHARMACEUTICAL DOSAGE FORMS WITH RAPID ACTIVE PRINCIPLE RELEASE
Title (de)
FESTE, ORAL APPLIZIERBARE PHARMAZEUTISCHE DARREICHUNGSFORMEN MIT SCHNELLER WIRKSTOFFFREISETZUNG
Title (fr)
FORMULATIONS DE PRESENTATION PHARMACEUTIQUES, SOLIDES ET ADMINISTREES PAR VOIE ORALE PRESENTANT UNE LIBERATION D'AGENTS ACTIFS RAPIDE
Publication
Application
Priority
- EP 2006009178 W 20060921
- DE 102005047561 A 20051004
Abstract (en)
[origin: US2010151011A1] The present invention relates to solid pharmaceutical dosage forms which can be administered orally and comprise 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide in amorphous form and/or thermodynamically metastable crystal modification and have rapid release of active ingredient, and to process for the production thereof, the use thereof as medicament, the use thereof for the prophylaxis, secondary prophylaxis and/or treatment of disorders, and to the use thereof for producing a medicament for the prophylaxis, secondary prophylaxis and/or treatment of disorders.
IPC 8 full level
A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 31/5377 (2006.01)
CPC (source: EP KR US)
A61K 9/1694 (2013.01 - EP US); A61K 9/20 (2013.01 - KR); A61K 9/2077 (2013.01 - EP US); A61K 31/5377 (2013.01 - KR); A61P 7/02 (2018.01 - EP); A61P 9/00 (2018.01 - EP); A61P 9/10 (2018.01 - EP)
Citation (examination)
- MALLICK S: "The Solid State Amorphization Of Poorly Water Soluble Drugs", INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, MEDKNOW PUBLICATIONS PVT LTD, IN, vol. 66, no. 6, 1 November 2004 (2004-11-01), pages 729 - 734, XP008143918, ISSN: 0250-474X
- ME AULTON (ED.): "Pharmaceutics. The science of dosage form design", 1 January 2002, CHURCHILL LIVINGSTONE, Edingburg, ISBN: 0443055173, article "Particle science and powder technology", pages: 142 - 144
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
US 2010151011 A1 20100617; US 8586082 B2 20131119; AR 056564 A1 20071010; AU 2006299192 A1 20070412; AU 2006299192 B2 20120419; BR PI0616874 A2 20110705; CA 2624306 A1 20070412; CA 2624306 C 20141209; CN 101321517 A 20081210; CN 101321517 B 20121128; CR 9864 A 20081031; CU 20080052 A7 20110426; CU 23808 B7 20120415; DE 102005047561 A1 20070405; DO P2006000209 A 20070430; EC SP088339 A 20080630; EP 1957048 A2 20080820; GT 200600445 A 20070508; HK 1127284 A1 20090925; IL 190618 A0 20081103; JP 2009510138 A 20090312; JP 5147703 B2 20130220; KR 101445398 B1 20140926; KR 20080067638 A 20080721; MY 143351 A 20110429; NZ 567094 A 20110527; PE 20070588 A1 20070817; RU 2008116831 A 20091110; RU 2440119 C2 20120120; SV 2009002857 A 20090114; TW 200803866 A 20080116; TW I389691 B 20130321; UA 90545 C2 20100511; UY 29835 A1 20070531; WO 2007039122 A2 20070412; WO 2007039122 A3 20071011; ZA 200802873 B 20090930
DOCDB simple family (application)
US 8914806 A 20060921; AR P060104365 A 20061004; AU 2006299192 A 20060921; BR PI0616874 A 20060921; CA 2624306 A 20060921; CN 200680045548 A 20060921; CR 9864 A 20080403; CU 20080052 A 20080404; DE 102005047561 A 20051004; DO 2006000209 A 20061002; EC SP088339 A 20080402; EP 06792199 A 20060921; EP 2006009178 W 20060921; GT 200600445 A 20061004; HK 09105035 A 20090604; IL 19061808 A 20080403; JP 2008533890 A 20060921; KR 20087010702 A 20060921; MY PI20080998 A 20060921; NZ 56709406 A 20060921; PE 2006001198 A 20061003; RU 2008116831 A 20060921; SV 2008002857 A 20080402; TW 95136623 A 20061003; UA A200805665 A 20060921; UY 29835 A 20061003; ZA 200802873 A 20080402